PharmaDrug Provides Development Update of Cepharanthine (PD-001) for Cancer and Infectious Disease bit.ly/3Zg80QA $PHRX $LMLLF | #cancer #esophageal #COVID19 #Cepharanthine #psychedelics #Australia 🇦🇺

PharmaDrug CEO Provides Vision for Securedose Acquisition Read more: bit.ly/3Tj2qw3 $PHRX $LMLLF | #psychedelics #pharmaceutical #securedose

PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement bit.ly/499b0Td $PHRX $LMLLF | #psychedelics #pharmaceutical #securedose #privateplacement

PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers bit.ly/4bxnEgh $PHRX $LMLLF | #psychedelics #pharmaceutical #securedose

PharmaDrug’s Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies bit.ly/3uxiosu $PHRX $LMLLF | #cancer #esophageal #COVID19 #Cepharanthine #psychedelics #Australia 🇦🇺

PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman bit.ly/3IcsWAm $PHRX $LMLLF | #cancer #esophageal #COVID19 #Cepharanthine #psychedelics

PharmaDrug’s SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine bit.ly/49MBdak $PHRX $LMLLF | #PharmaDrug #SecureDose #patent #biosynthetic #cocaine #pharmaceuticals #innovation #healthcare #news

PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine bit.ly/3UiDncv $PHRX $LMLLF | #PharmaDrug #SecureDose #patent #biosynthetic #cocaine #pharmaceuticals #innovation #healthcare #news

PharmaDrug’s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine bit.ly/44mhfRU $PHRX $LMLLF | #cancer #esophageal #Oncology #Cepharanthine #psychedelics #Australia 🇦🇺

PharmaDrug Provides Forward Plan to Move Its Patent Pending Process and Formulation of Pharmaceutical Grade Biosynthetic #Cocaine Through Development into Commercialization bit.ly/3ypNWln $PHRX $LMLLF | #PharmaDrug #SecureDose #patent #biosynthetic #pharmaceuticals

PharmaDrug’s Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine bit.ly/3WG6o3m $PHRX $LMLLF | #cancer #esophageal #Oncology #Cepharanthine #psychedelics #infectiousdiseases #Australia 🇦🇺

Pharmadrug's Securedose Announces LOI with Canadian Controlled Drug Substance Licensed Dealer for Patent Pending Pharmaceutical Grade #Cocaine bit.ly/3wDXjxE $PHRX $LMLLF | #PharmaDrug #SecureDose #patent #biosynthetic #pharmaceuticals #innovation #healthcare #news

PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated #Cepharanthine bit.ly/3X7DaKK $PHRX $LMLLF | #psychedelics #infectiousdiseases #cancer #clinicaltrials #DrugApproval #MedicalResearch #DrugDevelopment

PharmaDrug’s Sairiyo Therapuetics Announces Independent Screening Identifying Cepharanthine’s Potential to Bind to Monkeypox (Mpox) Proteins bit.ly/4cCRnUp $PHRX $LMLLF | #psychedelics #infectiousdiseases #MedicalResearch #monkeypox #DrugDevelopment #Cepharanthine

PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases tinyurl.com/bynvkz3x $PHRX $LMLLF | #infectiousdiseases #MedicalResearch #monkeypox #DrugDevelopment #Cepharanthine #Ebola #COVID

PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated #Cepharanthine) for Viral Infectious Diseases bit.ly/4eoFkLy $PHRX $LMLLF | #infectiousdiseases #MedicalResearch

PharmaDrug’s Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated #Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases tinyurl.com/826v5mbr $PHRX $LMLLF | #clinicaltrial #pharmaceuticals #healthcare

PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value bit.ly/45dis0u $PHRX $LMLLF | #StrategicReview #ShareholderValue #AssetOptimization #Cepharanthine #Biotech #ValueCreation #Restructuring #LifeSciences

PharmaDrug Announces Resignation of Rob Steen as CEO and From Board of Directors bit.ly/4e8gRLV $PHRX $LMLLF | #CEO #Cepharanthine #Biotech #LifeSciences

PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc. bit.ly/3Jbk8OP $PHRX $LMLLF | #Cepharanthine #Biotech #LifeSciences